Maria Concetta Fargnoli

Author PubWeight™ 39.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 2008 2.37
2 Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol 2009 2.26
3 Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 2007 1.72
4 Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy. Arch Dermatol 2006 1.58
5 A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet 2013 1.17
6 Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer 2009 1.15
7 The spectrum of dermatoscopic patterns in blue nevi. J Am Acad Dermatol 2011 1.11
8 Dermoscopic changes in acral melanocytic nevi during digital follow-up. Arch Dermatol 2007 1.10
9 MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer 2014 1.10
10 CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma. J Invest Dermatol 2004 1.04
11 Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatol Surg 2005 0.96
12 Dermoscopic features of actinic keratosis. J Dtsch Dermatol Ges 2007 0.95
13 MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis. Eur J Cancer 2012 0.95
14 Kaposi's sarcoma of the glans penis in an immunocompetent patient. Eur J Dermatol 2004 0.93
15 Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 2006 0.92
16 Interobserver agreement on dermoscopic features of pigmented basal cell carcinoma. Dermatol Surg 2002 0.91
17 Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. J Am Acad Dermatol 2006 0.89
18 The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. J Invest Dermatol 2006 0.89
19 Symmetric distribution of lupus erythematosus tumidus on the elbows. Eur J Dermatol 2006 0.88
20 Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial. Eur J Dermatol 2007 0.87
21 On the interplay of telomeres, nevi and the risk of melanoma. PLoS One 2012 0.87
22 Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R. BMC Genet 2008 0.87
23 Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk. Eur J Cancer 2009 0.84
24 Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna. Arch Dermatol 2006 0.83
25 Psoriasis, Kaposi's sarcoma and Hodgkin's disease in a patient with Down's syndrome. Dermatology 2004 0.81
26 Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies. BMC Med Res Methodol 2012 0.81
27 Letter: Changes in dermoscopic features in superficial basal cell carcinomas treated with imiquimod. Dermatol Surg 2007 0.80
28 A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy. Clinicoecon Outcomes Res 2009 0.80
29 Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy. Arch Dermatol 2005 0.79
30 Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity. J Am Acad Dermatol 2013 0.79
31 Rapid response of scalp psoriasis to ustekinumab. Eur J Dermatol 2012 0.77
32 Effective control of psoriasis by etanercept in a patient with HCV-related diseases. Eur J Dermatol 2008 0.77
33 Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis. Acta Derm Venereol 2002 0.77
34 Conventional treatment of actinic keratosis: an overview. Curr Probl Dermatol 2014 0.76
35 Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma. Dermatol Surg 2005 0.76
36 Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy. Int J Hematol 2008 0.76
37 Dermoscopic evolution of a congenital combined nevus in childhood. Dermatol Surg 2005 0.76
38 Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin. J Dermatolog Treat 2011 0.76
39 Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream. Eur J Dermatol 2003 0.75
40 MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair. BMC Med Genet 2012 0.75
41 Efalizumab-induced immune thrombocytopenia during retreatment. J Am Acad Dermatol 2008 0.75
42 Dermoscopic evolution of vascular pattern in two cases of amelanotic melanoma. Acta Derm Venereol 2010 0.75
43 Cutaneous amelanotic melanoma metastasis and dermatofibromas showing a dotted vascular pattern. Acta Derm Venereol 2004 0.75
44 The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative. Int J Dermatol 2014 0.75
45 A 72-year-old woman with papules and nodules at the site of previous mastectomy. Arch Pathol Lab Med 2005 0.75
46 Lessons on dermoscopy. Dermatol Surg 2002 0.75
47 Mesalazine-induced psoriasis in patients with inflammatory bowel diseases. Eur J Dermatol 2011 0.75
48 No evidence for linkage with melanoma in Italian melanoma-prone families. Cancer Epidemiol Biomarkers Prev 2008 0.75
49 Hypoepiluminescence microscopy of pigmented skin lesions: new approach to improve recognition of dermoscopic structures. Dermatol Surg 2006 0.75
50 Characterization of melanoma susceptibility genes in high-risk patients from Central Italy. Melanoma Res 2017 0.75
51 Widespread recurrent lichenoid papular eruption--quiz case. Arch Dermatol 2004 0.75
52 Acneiform follicular mucinosis of the head and neck region. Eur J Dermatol 2003 0.75
53 Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene. Acta Derm Venereol 2005 0.75
54 Immunopathogenesis of psoriasis: a possible role of TGFbeta/Smads pathway. Ital J Anat Embryol 2014 0.75
55 Giant dermatofibroma appearing during pregnancy. Acta Derm Venereol 2006 0.75
56 Microabrasion versus microabrasion followed by 15% trichloroacetic acid for treatment of cutaneous hyperpigmentations in adult females. Dermatol Surg 2003 0.75